QUINT SKIPTON: Open Payments
NPI 1043379985 · FULLERTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,401 in 130 payments from 18 companies in 2025. Trend: 2023 $2,877 · 2024 $3,292 · 2025 $2,401
Food & beverage: $2,201Education: $200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $389 |
| Janssen Biotech, Inc. | 18 | $312 |
| LEO Pharma Inc. | 13 | $291 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $253 |
| UCB, Inc. | 11 | $210 |
| PFIZER INC. | 12 | $202 |
| MAYNE PHARMA COMMERCIAL LLC | 20 | $170 |
| GENZYME CORPORATION | 7 | $169 |
| Incyte Corporation | 5 | $117 |
| Lilly USA, LLC | 2 | $58 |
Products named: TREMFYA, RINVOQ, Bimzelx, CIBINQO, DUPIXENT, ADBRY, SKYRIZI, OPZELURA.
Industry payments across CA — which companies pay providers there.
